Position in EXEL
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$236,029
New position
Shares Held
4,338
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#561
of 754 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $2,015,581 across 6 Biotechnology names. EXEL ranks #5 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,919 | $953,224 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
2,773 | $317,979 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,990 | $254,717 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
7,085 | $250,737 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
4,338 | $236,029 | |
| 6 | GOSS |
Gossamer Bio, Inc.
|
17,550 | $2,895 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,029 | 4,338 | Shares | Sole | 2026-07-22 | |
| No filing history on record for this holder in this stock. | ||||||